Olaparib/Temozolomide

N/A

Report date: 2026/02/14 20:00:22
NME

Base Information

Drug NameOlaparib/Temozolomide
Drug Alias NameGLIORA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) Polymerase 3 inhibitorsPoly (ADP-Ribose) polymerase 1 inhibitorsPoly (ADP-Ribose) Polymerase 2 inhibitors +[5] 
TargetsPoly (ADP-Ribose) Polymerase 2Poly (ADP-Ribose) Polymerase 3Poly (ADP-Ribose) polymerase 1 +[4] 
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsYes OlaparibTemozolomide
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevio Therapeutics LlpNanoform Finland PLC
China Registration ClassN/A

Develop Information

Active CompaniesNanoform Finland PLC
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A